Evidence map›Paper›PMID 35716228›Full record

ArticleJournal of computer-aided molecular design2022

Ligand-based and structure-based studies to develop predictive models for SARS-CoV-2 main protease inhibitors through the 3d-qsar.com portal.

Eleonora Proia, Alessio Ragno, Lorenzo Antonini, Manuela Sabatino, Milan Mladenovič, Roberto Capobianco, Rino Ragno

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of computer-aided molecular design, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Natural Compounds fromMedicinal chemistry (Shariqah (United Arab Emirates)) · 2025
    Article
  3. Viral proteases as therapeutic targets.Molecular aspects of medicine · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Eleonora ProiaDepartment of Drug Chemistry and Technology, Rome Center for Molecular Design, Sapienza University of Rome, P.le Aldo Moro 5, 00185, Rome, Italy.
Alessio RagnoDepartment of Computer, Control and Management Engineering "Antonio Ruberti", Sapienza University of Rome, Rome, Italy.
Lorenzo AntoniniDepartment of Drug Chemistry and Technology, Rome Center for Molecular Design, Sapienza University of Rome, P.le Aldo Moro 5, 00185, Rome, Italy.
Manuela SabatinoDepartment of Drug Chemistry and Technology, Rome Center for Molecular Design, Sapienza University of Rome, P.le Aldo Moro 5, 00185, Rome, Italy.
Milan MladenovičDepartment of Chemistry, Faculty of Science, Kragujevac Center for Computational Biochemistry, University of Kragujevac, Radoja Domanovića 12, P.O. Box 60, 34000, Kragujevac, Serbia.
Roberto CapobiancoDepartment of Computer, Control and Management Engineering "Antonio Ruberti", Sapienza University of Rome, Rome, Italy.
Rino RagnoDepartment of Drug Chemistry and Technology, Rome Center for Molecular Design, Sapienza University of Rome, P.le Aldo Moro 5, 00185, Rome, Italy. rino.ragno@uniroma1.it.
Sapienza University of Rome · ITUniversity of Kragujevac · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The main protease (M

Indexed as

COVID-19 Drug TreatmentQuantitative Structure-Activity RelationshipAntiviral AgentsCoronavirus 3C ProteasesHumansLigandsMolecular Docking SimulationProtease InhibitorsSARS-CoV-23C-like proteinase, SARS-CoV-2Antiviral AgentsCoronavirus 3C ProteasesLigandsProtease Inhibitors3-D QSARCOMBINELigand-based drug designSARS-Cov-2Structure-activity relationshipsStructure-based drug design

Identifiers

PMID35716228
PMCPMC9206107
OpenAlexW4283078854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.